Funding Briefs

The Burroughs Wellcome Fund offers the $350,000 George Herbert Hitchings Award for Innovative Methods to a scientist or group of scientists investigating novel approaches to drug design and discovery. Hitchings, who served as president of the Burroughs Wellcome Fund from 1971 to 1990, pioneered several important concepts in drug design. The award is intended to support investigators embarking on new lines of drug research who are not yet eligible for more traditional grants. Eligible projects

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Burroughs Wellcome Fund offers the $350,000 George Herbert Hitchings Award for Innovative Methods to a scientist or group of scientists investigating novel approaches to drug design and discovery. Hitchings, who served as president of the Burroughs Wellcome Fund from 1971 to 1990, pioneered several important concepts in drug design. The award is intended to support investigators embarking on new lines of drug research who are not yet eligible for more traditional grants.

Eligible projects include laboratory studies, development of theoretical concepts, or any combination of the two. Candidates should have M.D. or Ph.D. degrees and at least five years of research experience, and should conduct their research at institutions in the U.S. Only one candidate or team of candidates may apply from each institution.

Application deadline is April 1. For more information, contact The Burroughs Wellcome Fund, Drug Design and Discovery Award, 3030 Cornwallis Rd., Research Triangle Park, N.C. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies